Thousands of IO clinical trials are currently available to cancer patients, all of which are aiming to identify the next generation of potential life-saving treatments. However, it can be difficult to design trials that will be able to efficiently enroll patients, especially in the field of immunotherapy where mechanisms of action have increased in complexity. This webinar on October 15th described advances in AI application for analyzing electronic health record (EHR) data in order to better design immunotherapy clinical trials and more efficiently match potential patients. View the webinar for FREE on-demand HERE.
#Webinar#Policy#AIinIO